Nick Todd, PhD

Nick Todd, PhD has extensive work experience in the field of life sciences and research. Nick is currently working as a Senior Life Sciences Specialist at L.E.K. Consulting, where they started in February 2022. Prior to this role, they served as a Life Sciences Specialist at the same company from February 2022 to December 2022.

Before joining L.E.K. Consulting, Nick worked as a Scientific and Business Consultant at CytoAgents, Inc starting in September 2021.

From June 2016 to October 2021, Nick was a Graduate Student Researcher at the University of Pittsburgh School of Medicine, focusing on molecular pharmacology and Alzheimer's disease. During this time, they identified a novel role of G protein-coupled receptor kinases (GRKs) in modulating amyloid-beta pathology and investigated the cellular signaling mechanisms of GPR3 in Alzheimer's disease.

From January 2019 to March 2021, Nick worked as an Investment Due Diligence Analyst at BlueTree Capital Group. In this role, they conducted market research and analyzed business models for early-stage life science and technology companies seeking funding from the BlueTree investor network.

Prior to their professional experience, Nick served as a Neuropharmacology Research Fellow at the Walter Reed Army Institute of Research from May 2015 to June 2016, and as an Undergraduate Researcher at the University of Maryland School of Medicine from May 2013 to August 2014.

Overall, Nick Todd, PhD has a strong background in life sciences research, with experience in consulting, business development, and due diligence analysis.

Nick Todd, PhD completed their Bachelor's Degree in Chemistry from the University of Maryland. Following this, they pursued higher education at the University of Pittsburgh School of Medicine, where they obtained a Doctor of Philosophy (PhD) degree in Molecular Pharmacology.